Immune responses to cancer: are they potential biomarkers of prognosis?

Recent technical improvements in evaluations of immune cells in situ and immune monitoring of patients with cancer have provided a wealth of new data confirming that immune cells play a key role in human cancer progression. This, in turn, has revived the expectation that immune endpoints might serve...

Deskribapen osoa

Xehetasun bibliografikoak
Egile nagusia: Theresa L Whiteside
Formatua: Artikulua
Hizkuntza:English
Argitaratua: Frontiers Media S.A. 2013-05-01
Saila:Frontiers in Oncology
Gaiak:
Sarrera elektronikoa:http://journal.frontiersin.org/Journal/10.3389/fonc.2013.00107/full